Opportunities for Freshers B.Pharm, MSc, BSc in Quality Control at MSN Group
3 July 2025

Opportunities for Freshers B.Pharm, MSc, BSc in Quality Control at MSN Group

Are you passionate about quality and keen to build your career in the pharmaceutical industry? We are hiring enthusiastic and dedicated individuals for our Quality Control (QC) Department.
3 July 2025
Virtual Walk In Drive for B.Pharm, M.Pharm as Manufacturing Executive at Intas Pharma
Preparation of batch manufacturing records, process validation protocol/report of DP area and its associated records
3 July 2025
Walk in Drive at Baddi for M.Pharm, B.Pharm, MSc in Production, QA, QC at Macleods Pharma
2-6 years of experience in operating of Granulation Glatt, Compression fette, Coating, Primary Packing CVC, Labelling bulk packing, Auto Cartonator
3 July 2025
Openings for QA, QC, Manufacturing, Packing at Ajanta Pharma - M.Pharm, B.Pharm, M.Sc Apply
Exposure to OSD Manufacturing operations like Compression, Pellet coating, Capsule filling, Primary Packing & Secondary Packing. Expertise in e-BPR and e-log will be added advantage.
3 July 2025
Walk in for M.Pharm, B.Pharm, M.Sc in QA, QC, Production Formulation at Alkem Laboratories
 IPQA Mfg. & Packing, Shop floor activities, Review of equipment audit trails, BMR, BPR review, line clearance. Process Validation, equipment, Utility qualification.
3 July 2025
Applications are invited for Project Assistant at Agharkar Research Institute
1st class B.Sc or MSc in Life Sciences or Biotechnology. Three years of post qualification experience in nucleic acid deliversy via nanocarriers.
3 July 2025
Novartis shares phase III GCAptAIN trial results: Cosentyx falls short of primary goal in treating Giant Cell Arteritis
Novartis has announced the top-line results of its Phase III GCAptAIN study, evaluating Cosentyx (secukinumab) in patients with giant cell arteritis (GCA) a serious inflammatory condition that primarily affects adults over the age of 50.
3 July 2025
Merck’s Winrevair™ (sotatercept-csrk) earns FDA priority review based on impressive ZENITH trial results
Merck has announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a supplemental Biologics License Application (sBLA) for Winrevair (sotatercept-csrk).
3 July 2025
Scientists discover Alzheimer’s-Linked Protein drives lung cancer spread to the brain, offering new treatment hope
In a major scientific breakthrough, researchers from McMaster University, Cleveland Clinic, and the Case Comprehensive Cancer Center have uncovered how a protein commonly linked to Alzheimer’s disease also plays a critical role in the spread of lung cancer to the brain. The discovery could pave the way for repurposing existing Alzheimer’s drugs to halt or slow brain metastases in cancer patients.
3 July 2025
Novel MRI Technique Maps Brain Metabolism to Reveal Disease Signatures
Researchers at the University of Illinois Urbana-Champaign have developed an innovative magnetic resonance imaging (MRI) method capable of noninvasively mapping metabolic activity in the brain, offering new insights into neurological diseases.